What's Happening
- Opentrons Labworks secured $40 million in Series E funding to expand its robotics and software tools, SiliconANGLE reports.
- Healthcare investor Avego led the round, with participation from BroadOak Capital Partners.
- The company builds benchtop robots and AI software that automate repetitive experimental work like liquid handling and sample preparation.
Why It Matters
Physical laboratory work remains a bottleneck in scientific research despite advances in artificial intelligence. Automating routine tasks like pipetting and DNA extraction allows researchers to run continuous experimental loops and accelerate drug discovery.
Members read this in full
Membership is free. Sign in with your work email or with LinkedIn.
Join CIOs and AI leaders from Citibank, Pfizer and more
or continue with email
Have an invite? Open your invite link to join instantly.
